佰金生命科学(01466)完成发行合共6535.94万股 净筹约3127.3万港元

智通财经
03 Apr

智通财经APP讯,佰金生命科学(01466)发布公告,认购协议所载先决条件已获达成,且完成已于2025年3月28日落实。根据认购协议的条款及条件,合共6535.94万股认购股份将以认购价每股认购股份0.48港元配发及发行予认购人。

认购事项所得款项总额为3137.3万港元,而认购事项所得款项净额(扣除相关开支后)约为3127.3万港元。预期认购事项所得款项净额将用作集团的一般营运资金。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10